Position in PRGO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,633,439
+$2,160,879 QoQ
Shares Held
253,459
+476.0% QoQ
Ownership
0.183%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#67
of 334 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Derivatives in PRGO
reported options exposure · as of Jun 30, 2026CallValue
$5,195,000
CallShares
500,000
PutValue
$5,195,000
PutShares
500,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $32,819,609 across 14 Drug Manufacturers - Specialty & Generic names. PRGO ranks #5 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
258,331 | $8,752,254 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
9,333 | $5,056,899 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
29,500 | $4,971,930 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
40,000 | $3,311,200 | |
| 5 | PRGO |
PERRIGO Co plc
This page
|
253,459 | $2,633,439 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
25,000 | $1,598,750 | |
| 7 | XERS |
Xeris Biopharma Holdings, Inc.
|
197,863 | $1,567,074 | |
| 8 | EOLS |
Evolus, Inc.
|
216,316 | $1,501,233 |
All Filings in PRGO
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,195,000 | 500,000 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $5,195,000 | 500,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $2,633,439 | 253,459 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $472,560 | 44,000 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $2,449,700 | 110,000 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $3,006,450 | 135,000 | Put | Sole | 2025-11-14 | |
| 2025-03-31 | $566,408 | 20,200 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,213,512 | 47,200 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $642,750 | 25,000 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $1,049,200 | 40,000 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $1,731,180 | 66,000 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $2,358,077 | 89,900 | Put | Sole | 2024-11-14 | |
| 2024-06-30 | $1,284,000 | 50,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,834,830 | 57,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,376,480 | 136,000 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $2,655,045 | 83,100 | Put | Sole | 2023-11-14 | |
| 2023-09-30 | $2,655,045 | 83,100 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $2,076,750 | 65,000 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||